Google Alert - pharmaceutical news

News 9 new results for pharmaceutical news

Pharmaceutical firms giving more importance to profits than new medical ... Newstrack India London, Aug 8 (ANI): The multi-billion pound pharmaceutical industry is putting profit ahead of medical discoveries, and are spending vastly more on marketing than on new treatments, scientists have warned. According to scientists, the industry has spent the ... See all stories on this topic »

K-V Pharmaceutical Class A and Class B Common Stock Begin Trading on the ... Sacramento Bee ST. LOUIS, Aug. 7, 2012 -- /PRNewswire/ -- K-V Pharmaceutical Company ("K-V" or "the Company") today announced that its Class A and Class B common shares have begun trading on the OTCQB Marketplace. The Company's Class A and Class B common ... See all stories on this topic »

KV Pharmaceutical "First Day" Motions Approved by US Bankruptcy Court Stockhouse 8, 2012 /PRNewswire/ -- K-V Pharmaceutical Company ("K-V" or "the Company") today announced that all "First Day" motions presented to the U.S. Bankruptcy Court on August 7, 2012 that were included as part of the Company's initial filings in its voluntary ... See all stories on this topic »

Auxilium Pharmaceuticals, Inc. To Present At The Canaccord Genuity 32nd ... Daily Markets Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company with a focus on developing and marketing products to predominantly specialist audiences. Auxilium markets Testim® 1% (testosterone gel) for the topical treatment of hypogonadism in ... See all stories on this topic »

Biostar Pharmaceuticals, Inc. To Establish A Call Center As Its New B2C Sales ... Daily Markets Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary and controlled affiliate in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The Company's most popular ... See all stories on this topic »

Somaxon Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call ... Seeking Alpha Good afternoon, everyone, and thank you for joining us today to discuss Somaxon Pharmaceuticals' second quarter 2012 financial results. On the call today are Richard Pascoe, the company's President and Chief Executive Officer; and Tran Nguyen, the ... See all stories on this topic »

Auxilium Pharmaceuticals Inc. Stock Upgraded (AUXL) TheStreet.com NEW YORK (TheStreet) -- Auxilium Pharmaceuticals (Nasdaq:AUXL) has been upgraded by TheStreet Ratings from sell to hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with ... See all stories on this topic »

Integrated Pharmaceutical Market Research Teams are More Proactive, Finds ... eYugoslavia.com The most efficient market research teams are able to anticipate stakeholder needs and have the autonomy to proactively run necessary research studies to support their products. Unfortunately, many market research teams are structured so that they are not ... See all stories on this topic » eYugoslavia.com

Alembic Pharma inks pact with Accu-Break Pharma Myiris.com Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company on Wednesday announced that they have entered into a development and license agreement with Accu-Break Pharmaceuticals, USA (ABP) to develop new ... See all stories on this topic » Myiris.com

---

Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.